Targeting TAMs to produce pro-inflammatory cytokines, such as IFN-γ and TNF-α, can promote an immune-favorable microenvironment while also producing T cell-specific chemokines, such as CXCL9, to recruit T cells to the tumor. The gene discussed is TNF; the disease is neoplasm.